Antithrombotic treatment for newly diagnosed atrial fibrillation in relation to patient age: the GLORIA-AF registry programme

Michał Mazurek; Jonathan L. Halperin; Menno V. Huisman; Hans‐Christoph Diener; Sérgio Dubner; Chang Sheng; Kenneth J. Rothman; Jeff S. Healey; Christine Teutsch; Miney Paquette; Lionel Riou França; Shihai Lu; Dorothee B. Bartels; Professor Gregory Lip

doi:10.1093/europace/euz278

Related publications

Article2023

Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry

Xiaoxia Liu, Guoze Feng, Sabrina Marler, Menno V. Huisman, Professor Gregory Lip, Changsheng Ma

Article2018

Gender Differences in Antithrombotic Treatment for Newly Diagnosed Atrial Fibrillation: The GLORIA-AF Registry Program

Michał Mazurek, Menno V. Huisman, Kenneth J. Rothman, Miney Paquette, Christine Teutsch, Hans‐Christoph Diener, Sérgio Dubner, Jonathan L. Halperin, Kristina Zint, Lionel Riou França, Shihai Lu, Professor Gregory Lip

Article2024

Machine learning for outcome prediction in patients with non-valvular atrial fibrillation from the GLORIA-AF registry

Martha Joddrell, Wahbi K. El‐Bouri, Stephanie L. Harrison, Menno V. Huisman, Professor Gregory Lip, Yalin Zheng

Article2022

Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry

Professor Gregory Lip, Agnieszka Kotalczyk, Christine Teutsch, Hans‐Christoph Diener, Sérgio Dubner, Jonathan L. Halperin, Changsheng Ma, Kenneth J. Rothman, Sabrina Marler, Venkatesh Kumar Gurusamy, Menno V. Huisman, Dzifa Wosornu Abban, Emad F. Aziz, Marica Bracic Kalan, Nasser Abdul, Luciano Marcelo Backes, Drew Bradman, Atilio Marcelo Abud, Erik Badings, Donald Brautigam, Fran Adams, Ermentina Bagni,

Article2017

Systolic Blood Pressure Visit-to-Visit Variability and Major Adverse Outcomes in Atrial Fibrillation

Marco Proietti, Giulio Francesco Romiti, Brian Olshansky, Professor Gregory Lip